APA (7th ed.) Citation

RL, W., SG, C., JH, L., F, W., M, H., AH, B., . . . L, Z. (2025). Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products. Pharmaceutical research, 42(11), 1917. https://doi.org/10.1007/s11095-025-03937-w

Chicago Style (17th ed.) Citation

RL, Walenga, Chopski SG, Lee JH, Wang F, Hu M, Babiskin AH, Fang L, and Zhao L. "Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products." Pharmaceutical Research 42, no. 11 (2025): 1917. https://doi.org/10.1007/s11095-025-03937-w.

MLA (9th ed.) Citation

RL, Walenga, et al. "Using Lung Regional Deposition Modeling as Model-Integrated Evidence for Locally Acting Orally Inhaled Drug Products." Pharmaceutical Research, vol. 42, no. 11, 2025, p. 1917, https://doi.org/10.1007/s11095-025-03937-w.